Press release
North America Leads Cancer Vaccines Market Projected to grow US$ 14.96 Billion by 2033, Russian Pembrolizumab Cleared in Vietnam Market
Cancer Vaccines Market Size
✅ The North America cancer vaccines market was valued at USD 3.90 billion in 2024, driven by strong R&D investment and advanced oncology infrastructure.
✅ The Asia-Pacific cancer vaccines market reached USD 2.17 billion in 2024, supported by rising cancer prevalence and expanding clinical research activity.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/cancer-vaccines-market?kb
Latest M & A
• BioNTech SE completes acquisition of CureVac N.V. in an all-stock deal valued at US$1.25 billion, consolidating mRNA cancer vaccine and immunotherapy assets under one platform.
• CureVac exits public markets following acquisition by BioNTech, with shares suspended and the company now integrated as part of BioNTech's oncology and mRNA vaccine operations.
Major Growing Players:
Merck & Co., Inc., GlaxoSmithKline plc (GSK), and Dendreon Pharmaceuticals LLC
Emerging Players
The emerging players in the cancer vaccines market include Candel Therapeutics, Elicio Therapeutics, Evaxion, Imugene, Nouscom, OSE Immunotherapeutics, Scancell, and Takis
Key Developments:
🔹 January 2026
• USA: mRNA-based personalized cancer vaccines advance toward late-stage clinical trials, supported by strong NIH and biotech funding momentum.
• Japan: Japanese researchers report improved immune response data for peptide-based cancer vaccines targeting solid tumors.
• Europe: EU regulators accelerate adaptive clinical trial pathways for therapeutic cancer vaccines to reduce approval timelines.
🔹 December 2025
• USA: Leading biopharma firms expand AI-driven neoantigen discovery platforms to scale personalized cancer vaccine development.
• Japan: Strategic academia-industry collaborations strengthen Japan's pipeline for next-generation dendritic cell cancer vaccines.
• Europe: European biotech startups secure fresh funding to advance mRNA and viral-vector cancer vaccines into Phase II trials.
🔹 November 2025
• USA: FDA grants fast-track designation to multiple therapeutic cancer vaccines targeting melanoma and lung cancer.
• Japan: Clinical studies highlight promising safety profiles of combination cancer vaccines used alongside immune checkpoint inhibitors.
• Europe: Pan-European research consortia launch cross-border programs to develop off-the-shelf cancer vaccines for common tumor types.
Forecast Projection:
The Global Cancer Vaccines Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Research Process:
Global Cancer Vaccines Market report is built on solid intelligence - powered by both primary and secondary research. Our analysts have deep-dived into every factor that can influence your business roadmap, including government regulations, competitive landscape, tech innovations, historical market behavior, upcoming breakthroughs, adjacent industry trends, market volatility, growth prospects, and potential risks.
Vietnam authorizing the Russian Pembrolizumab Cancer Drug:
✅ Vietnam's Ministry of Health approved Pembroria, a Russian-made cancer immunotherapy containing pembrolizumab, for circulation in the country in late 2025.
✅ The drug has been registered for three-year market authorization and can be distributed nationwide after regulatory review.
✅ Pembroria is indicated for multiple cancer types, including lung, melanoma, colorectal, cervical, renal, and breast cancers.
✅ Hospitals such as Hanoi's K Hospital are preparing to integrate the drug into treatment protocols, though insurance coverage is not yet available.
Buy Now & Get 30% OFF - (Grab 50% OFF on 2+ reports): https://www.datamintelligence.com/buy-now-page?report=cancer-vaccines-market?kb
Key Segments:
By Type: Preventive Cancer Vaccines, Therapeutic Cancer Vaccines
By Cancer Type: Prostate Cancer, Cervical Cancer, Lung Cancer, Bladder Cancer, Others
By Technology: Protein-based, Nucleic acid-based (DNA, RNA/mRNA), Whole-cell, Viral vector, Dendritic cell, Recombinant/adjuvant.
By Route of Administration: Intramuscular, Intravenous, Others
By End User: Hospitals, Clinics, Cancer Treatment Centers, Government Entities, Other
Regional Analysis for Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Benefits of the Report:
Chapter 1: sets the stage by defining the full scope of the report and delivering an executive summary of key market segments across regions, product types, and applications. It provides a comprehensive snapshot of current market sizes and reveals future growth potential, offering a clear vision of how the market will evolve in the short, mid, and long term.
Chapter 2: uncovers critical insights and highlights the most impactful emerging trends shaping the Cancer Vaccines market's future - essential knowledge for investors and strategists looking to stay ahead.
Chapter 3: dives deep into the competitive landscape, delivering an in-depth analysis of Cancer Vaccines manufacturers. It covers market share dynamics, strategic developments, and the latest mergers and acquisitions that are redefining the industry.
Chapter 4: profiles the market's leading players, offering detailed views of their revenue streams, profit margins, product portfolios, and recent innovations - arming you with the intel to benchmark and strategize effectively.
Chapters 5 & 6: break down revenue performance by region and country, providing a quantitative analysis that spotlights growth hotspots, development prospects, and the unique opportunities each market offers across the globe.
Chapter 7: explores market segmentation by type, revealing the size and untapped potential of each segment - guiding you toward lucrative "blue ocean" opportunities that competitors may have overlooked.
Chapter 8: analyzes the market by application, evaluating downstream sectors with the highest growth potential and identifying promising areas for expansion and investment.
Chapter 9: maps the entire industry supply chain, tracing upstream suppliers to downstream distributors, giving you full visibility into critical business linkages and value drivers.
Chapter 10: wraps up with a powerful summary of the report's key findings and strategic takeaways, delivering the must-know insights every industry stakeholder needs to make confident, forward-looking decisions.
Get Customization in the report as per your requirements: https://datamintelligence.com/customize/cancer-vaccines-market?kb
FAQ's
Q1: How fast Cancer Vaccines Market Growing?
A: The Cancer Vaccines Market was valued at US$ 8.82 Billion in 2023 and is on track for explosive expansion Growth with US$ 9.27 Billion in 2024, projected to hit US$ 14.96 Billion by 2033
Q2: How fast is the Cancer Vaccines Market growing?
A: The Market is set to surge with an impressive CAGR of 5.5% between 2025 and 2033
Contact Us For Custom Research: https://www.datamintelligence.com/custom-research?kb
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release North America Leads Cancer Vaccines Market Projected to grow US$ 14.96 Billion by 2033, Russian Pembrolizumab Cleared in Vietnam Market here
News-ID: 4382311 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Future of Automotive Power Electronics Industry Sector (2026-2033) | Silicon Car …
DataM Intelligence has released a new research report titled "Automotive Power Electronics Market Size 2026" The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in…
Polymer Microinjection Molding Market (2026) | Microinjection Molding , Precisio …
DataM Intelligence has released a new research report titled "Polymer Microinjection Molding Market Size 2026" The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in…
Carbon Capture Power Plants & Storage Systems Market (2026) | CCS Deployment, CO …
DataM Intelligence has released a new research report titled "Carbon Capture Power Plants and Storage Systems Market Size 2026" The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the…
Future of Operational Intelligence (OI) Market (2026) | Real-Time Analytics, AI …
DataM Intelligence has released a new research report titled "Operational Intelligence Market Size 2026" The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
